GET DAILY SIGNALSBowhead Specialty (BOW) Reports +19.3% Revenue Growth in Q3 2026
Key Takeaways
- Total revenue rose 19.3% year over year to $171.8 million in the third quarter of 2026, essentially in line with consensus estimates.
- GAAP diluted earnings per share (EPS) of $0.38 came in below the analyst estimate of roughly $0.50, while adjusted diluted EPS of $0.54 exceeded expectations.
- Gross written premiums climbed 10.8% to $256.4 million, led by a 155.4% surge in the Baleen Specialty digital division.
- The combined ratio — a key measure of underwriting profitability — edged up slightly to 95.9%, still comfortably below the 100% breakeven threshold.
- Net income declined 14.7% to $12.9 million due to higher non-operating and financing costs, while adjusted net income grew 16.0% to $18.4 million.
- Results arrived against the backdrop of the pending acquisition by American Family announced on August 3, 2026, which led the company to cancel its earnings conference call.
- For more context, explore Bowhead Specialty's Major News, Today's Price Move, Price Targets, and Forecast pages.
- You can also discover additional ideas by exploring Trending AI Robots.
Why This Report Stands Out
Bowhead Specialty Holdings focuses on specialty casualty, professional liability, and healthcare liability coverage through wholesale brokers and managing general agents. The third-quarter results carry added significance given the pending acquisition by American Family, announced on August 3, 2026, which led the company to skip its usual earnings call. In my view, this leaves investors relying more heavily on the raw numbers to assess underwriting discipline and premium momentum. Earlier periods had shown steady double-digit premium growth and a steady loss ratio, so this update serves as an important checkpoint on whether those patterns hold as the deal moves toward completion.
A Closer Look at the Figures
For the three months ended September 30, 2026, BOW posted total revenue of $171.8 million, up 19.3% from the same quarter last year. GAAP diluted EPS landed at $0.38, short of the roughly $0.50 consensus, yet adjusted diluted EPS reached $0.54 after stripping out non-operating items, foreign exchange effects, and certain strategic costs, beating the $0.50 to $0.51 range. Gross written premiums rose 10.8% to $256.4 million, powered by a 155.4% jump in the Baleen Specialty digital unit, while Casualty, Professional Liability, and Healthcare Liability segments all contributed growth. Net earned premiums increased 17.0% to $150.2 million. The loss ratio moved up 1.4 points to 67.3%, the expense ratio improved to 28.6%, and the combined ratio came in at 95.9%. Net investment income climbed 36.7% to $20.6 million, and book value per share advanced 4.6% to $13.75. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
How the Market Responded
Shares of BOW climbed about 2.3% to $34.75 right after the release. The modest gain suggests investors focused on the stronger adjusted results and underlying underwriting trends rather than the GAAP miss tied to merger and financing costs. With the American Family deal in focus, standalone valuation discussions have taken a back seat, and the lack of a conference call means the raw metrics carry extra weight.
What Comes Next
The American Family transaction remains the primary near-term driver, so the closing timeline and any regulatory steps will be key. Without forward guidance or a call, attention stays on reported trends. Underwriting performance deserves close watching, particularly whether the loss ratio holds within its recent range and the combined ratio stays below 100%. The fast growth in the digital and small-business platform also matters, as it expands opportunities while shifting the risk mix. Investment income trends, expense control, and the scaling of the digital business will help determine if adjusted profitability continues to improve.
Using AI Tools in My Research
From what I see, tools like Tickeron’s AI Screener help quickly filter for patterns and fundamentals around earnings events. I’ve found it useful for spotting comparable names and refining ideas without spending hours on manual screens.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BOW's RSI Indicator peaks and leaves overbought zone
The 10-day RSI Indicator for BOW moved out of overbought territory on October 28, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 instances where the indicator moved out of the overbought zone. In 13 of the 17 cases the stock moved lower in the days that followed. This puts the odds of a move down at 76%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
BOW broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on BOW as a result. In 25 of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where BOW advanced for three days, in 91 of 138 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 65 of 91 cases where BOW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating fairly steady price growth. BOW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 61 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.360) is normal, around the industry mean (-2.452). P/E Ratio (17.963) is within average values for comparable stocks, (9.201). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.303). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (1.836) is also within normal values, averaging (1.594).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BOW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 51, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PropertyCasualtyInsurance
Advertisement